Dial Pharmaceuticals Private Limited

Dial Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24231GJ2003PTC042823 Incorporated 01 September 2003 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹3.84 Cr
▼ 3% YoY
Net loss · FY 2025
₹1.21 Cr
Net margin -31.6%
EBITDA · FY 2025
-₹1.32 Cr
EBITDA margin -34.3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹4.75 Cr
Satisfied ₹16.06 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
30
Provident fund records

About Dial Pharmaceuticals Private Limited

Data last updated:

Dial Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 September 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2003PTC042823. Its GSTIN is 24AABCD9072H1ZO (Gujarat).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Rannaben Sanjaybhai Sheth and Bindiben Jayeshbhai Sheth.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3701 / A Phase Ivg I D C Estate Vatva, Ahmedabad, Gujarat, India – 382445.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.84 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹1.21 Cr (net margin -31.6%) and EBITDA of -₹1.32 Cr (EBITDA margin -34.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.

The company has about 30 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹4.75 Cr and satisfied charges of ₹16.06 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 2 cases are pending.

Dial Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0075743). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dialpharmaceuticals.com.

Company details

CIN U24231GJ2003PTC042823
Registration Number 042823
Incorporation Date 01 September 2003
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0075743

Recognitions & Rankings of Dial Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-01-0075743

Contact details

Dial Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is dialpharmaceuticals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    3701 / A Phase Ivg I D C Estate Vatva, Ahmedabad, Gujarat, India – 382445
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dial Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Dial Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dial Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Dial Pharmaceuticals Private Limited, buy the company report.

Financials of Dial Pharmaceuticals Private Limited

FY 2025 filings available

Dial Pharmaceuticals Private Limited reported revenue of ₹3.84 Cr (down 3% YoY) for FY 2025.

Revenue · FY 2025
₹3.84 Cr ▼ 3%
Net loss · FY 2025
₹1.21 Cr margin -31.6%
EBITDA · FY 2025
-₹1.32 Cr margin -34.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 7%
5 years · compounded
▼ 7%
EBITDA CAGR growth
3 years · compounded
▼ 110%
5 years · compounded
▼ 36%

Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 3% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.32 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.21 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-34.3%
Net Profit Margin-31.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dial Pharmaceuticals Private Limited, buy the company report.

Board of directors of Dial Pharmaceuticals Private Limited

Dial Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sharadchandra Rasiklal ShahAdditional Director07 Aug 20251 Years 3 MonthsCurrent
Darshan Sharadchandra ShahAdditional Director07 Aug 20251 Years 3 MonthsCurrent
Rannaben Sanjaybhai ShethDirector01 Sep 200323 Years 2 MonthsCurrent
Bindiben Jayeshbhai ShethDirector01 Sep 200323 Years 2 MonthsCurrent

Peer comparison

Dial Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Olwen Lifesciences Private Limited₹3.85 Cr (FY 2024)137.0%Ahmedabad, Gujarat, India
Samai Healthcare Private Limited₹3.84 Cr (FY 2024)15.0%Mumbai, Maharashtra, India
Dial Pharmaceuticals Private Limitedthis company₹3.84 Cr (FY 2025)-₹1.21 Cr-31.6%-3.0%30Ahmedabad, Gujarat, India
Alive Lifescience Private Limited₹3.83 Cr (FY 2025)3.0%Ahmedabad, Gujarat, India
Dharuhera Pharmaceuticals Pvt Ltd₹3.83 Cr (FY 2025)-79.0%New Delhi, Delhi, India
Alentica Pharmaceuticals Private Limited₹3.83 Cr (FY 2025)16.0%Hyderabad, Telangana, India

To see the full peer comparison of Dial Pharmaceuticals Private Limited, buy the company report.

Auditor

Dial Pharmaceuticals Private Limited is audited by Pankaj K. Shah & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Pankaj K. Shah & Co.FY 2024107351W

Shareholding

The shareholding of Dial Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dial Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.75 Cr
Satisfied charges
₹16.06 Cr
Breakdown by lending institutions
Others₹4.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Sep 2025101151772Others₹4.75 CrOpen
27 Nov 2020100414632Others₹2.9 CrSatisfied
16 Jun 2020100341105Sidbi₹50 LakhSatisfied
17 Dec 2019100354092Others₹7.48 CrSatisfied
17 Jun 2017100107301Others₹2.38 CrSatisfied

To see the full charge records of Dial Pharmaceuticals Private Limited, buy the company report.

Total charge records: 8 View all charges

Credit ratings & regulatory alerts

Dial Pharmaceuticals Private Limited was last rated by Care on 30 May 2022.

Rating agencyRated onRating
Care30 May 2022

To see the full credit ratings and regulatory alerts of Dial Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

Dial Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 34 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 10)

SupplierAmount dueDue sinceReported on
Dhruvi Offset
Meghna Granules
Dhruvi Offset
Aum Research Laboratories
Pacemaker Pharma Chem

To see the full MSME payment records of Dial Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Dial Pharmaceuticals Private Limited has a workforce of 30 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
30
Active EPFO establishments
2
Employee growth
-25%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2730
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Dial Pharmaceuticals Private Limited, buy the company report.

GST

Dial Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AABCD9072H1ZOGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Dial Pharmaceuticals Private Limited, buy the company report.

Recent activity

Dial Pharmaceuticals Private Limited has 7 board changes on record since 2003: 4 appointments and 3 cessations. The latest: Darshan Sharadchandra Shah was appointed as Additional Director on 07 Aug 2025.

AGM
Dial Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 475.00 Lakh with Charge ID 101151772 was registered on 06 Sep 2025.
Appointed
Darshan Sharadchandra Shah was appointed as Additional Director.
Appointed
Sharadchandra Rasiklal Shah was appointed as Additional Director.
Ceased
Sanjay Jamnadas Sheth ceased to be Director.
Charges
A charge registered on 17 Dec 2019 via Charge ID 100354092 with Others was fully satisfied on 24 Apr 2025.
Filing
Dial Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 27 Nov 2020 via Charge ID 100414632 with Others was fully satisfied on 13 Mar 2025.
Ceased
Jayeshkumar Jamnadas Sheth ceased to be Director.
Charges
A charge registered on 16 Jun 2020 via Charge ID 100341105 with Sidbi was fully satisfied on 20 Sep 2022.
Charges
A charge with Others amounted to Rs. 289.91 Lakh with Charge ID 100414632 was registered on 27 Nov 2020.
Charges
A charge with Sidbi amounted to Rs. 50.00 Lakh with Charge ID 100341105 was registered on 16 Jun 2020.

17 earlier events are in the company report.

Frequently asked questions

Dial Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 September 2003 (23+ years old) and is registered under CIN U24231GJ2003PTC042823.

Dial Pharmaceuticals has 4 current directors:

The latest financial statements of Dial Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dial Pharmaceuticals is 24AABCD9072H1ZO, registered in Gujarat.

The CIN (Corporate Identification Number) of Dial Pharmaceuticals is U24231GJ2003PTC042823. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dial Pharmaceuticals has 4 court cases on record: 4 filed against it. 2 are pending.

Dial Pharmaceuticals was incorporated on 01 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Dial Pharmaceuticals by revenue are Olwen Lifesciences Private Limited, Samai Healthcare Private Limited, Alive Lifescience Private Limited, Dharuhera Pharmaceuticals Pvt Ltd, Alentica Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Darshan Sharadchandra Shah was appointed as Additional Director on 07 Aug 2025. Sharadchandra Rasiklal Shah was appointed as Additional Director on 07 Aug 2025. Sanjay Jamnadas Sheth ceased to be Director on 09 Jun 2025. Dial Pharmaceuticals has 7 board changes on record in total.

Yes, Dial Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0075743).

Dial Pharmaceuticals has 3 MSME Form 1 returns on record between 2019 and 2021, listing 34 overdue payments to 10 micro and small suppliers. The latest return was filed on 13 May 2021.

Dial Pharmaceuticals can be reached through the website dialpharmaceuticals.com. Its registered office is in Ahmedabad, Gujarat, India.